NCT03819907

Brief Summary

The management of chronic pain is a significant public health issue related to escalating treatment costs, lost productivity, disability and medication use. The prevalence of chronic pain is rising alarmingly across all subpopulations with chronic low back pain (LBP) being labeled as one of the 15 most expensive medical conditions. Both study investigators are involved in the medical treatment of these patients. The investigators are interested in testing the effectiveness of alternative treatment strategies that address the complexity of chronic pain that is often mediated not only by physiologic variables, but also psychosocial issues. There is emerging evidence that Virtual Reality (VR) may be an effective pain management tool to augment care in this population, reducing medical costs, decreasing medication use, improving outcomes and empowering patients to take more control over their own health and management of chronic pain. Less is known about the use of this technology delivered in the context of care delivered in an outpatient clinical setting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 29, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

April 8, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 9, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

February 23, 2021

Status Verified

February 1, 2021

Enrollment Period

3 months

First QC Date

January 17, 2019

Last Update Submit

February 22, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change is being assessed between two time points by The Numeric Pain Rating Scale

    Self-report current pain rating on a 0-10 scale with 0 being no pain and 10 being the worst pain imaginable

    First time point: At the beginning of the injection clinic visit, prior to receiving the injection. Second time point: approximately 1 hour later, at the conclusion of the injection clinic visit, after receiving the injection

Secondary Outcomes (2)

  • Change is being assessed between two time points by The Anxiety Thermometer

    First time point: At the beginning of the injection clinic visit, prior to receiving the injection. Second time point: approximately 1 hour later, at the conclusion of the injection clinic visit, after receiving the injection

  • Virtual Reality Symptom Questionnaire

    Measured at one time point approximately 1 hour from the time of randomization

Other Outcomes (1)

  • Interest questions about the guided relaxation content

    Measured at one time point approximately 1 hour from the time of randomization

Study Arms (3)

Control

NO INTERVENTION

15 participants will be randomly assigned to the control group. They will receive no intervention other than the injection (which is not a part of the trial). Pre-injection they will receive all baseline measures and questionnaires. Post injection they will receive the primary outcome measures: 1) Numeric Pain Rating Scale and 2) Anxiety thermometer

Audiovisual (AV) Guided Relaxation

ACTIVE COMPARATOR

Combination Product: Audiovisual Guided Relaxation Five-minute guided relaxation delivered via a computer screen and speakers

Combination Product: Audiovisual Guided Relaxation

Virtual Reality (VR) Guided Relaxation

EXPERIMENTAL

Combination Product: Virtual Reality Guided Relaxation Five-minute guided relaxation delivered via a Samsung Galaxy 7s and the Samsung adaptable VR headset. Other Names: • Samsung Galaxy 7s/Samsung adaptable VR headset

Combination Product: Virtual Reality Guided Relaxation

Interventions

Five-minute guided relaxation delivered via a computer screen and speakers

Audiovisual (AV) Guided Relaxation

Five-minute guided relaxation delivered via a Samsung Galaxy 7s and the Samsung adaptable VR headset.

Virtual Reality (VR) Guided Relaxation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients attending an appointment to receive a lumbar spinal injection.
  • Patients meeting the definition of chronic LBP as established by the NIH task force: Back pain problem that has persisted at least 3 months, and has resulted in pain on at least half the days in the past 6 months

You may not qualify if:

  • Age younger than 18 years
  • Not being fluent and literate in English
  • Patients receiving injections in areas other than the lumbar or pelvic region

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Related Publications (10)

  • Ames SL, Wolffsohn JS, McBrien NA. The development of a symptom questionnaire for assessing virtual reality viewing using a head-mounted display. Optom Vis Sci. 2005 Mar;82(3):168-76. doi: 10.1097/01.opx.0000156307.95086.6.

    PMID: 15767873BACKGROUND
  • Deyo RA, Dworkin SF, Amtmann D, Andersson G, Borenstein D, Carragee E, Carrino J, Chou R, Cook K, DeLitto A, Goertz C, Khalsa P, Loeser J, Mackey S, Panagis J, Rainville J, Tosteson T, Turk D, Von Korff M, Weiner DK. Report of the NIH Task Force on research standards for chronic low back pain. J Pain. 2014 Jun;15(6):569-85. doi: 10.1016/j.jpain.2014.03.005. Epub 2014 Apr 29.

    PMID: 24787228BACKGROUND
  • Chan E, Foster S, Sambell R, Leong P. Clinical efficacy of virtual reality for acute procedural pain management: A systematic review and meta-analysis. PLoS One. 2018 Jul 27;13(7):e0200987. doi: 10.1371/journal.pone.0200987. eCollection 2018.

    PMID: 30052655BACKGROUND
  • Childs JD, Piva SR, Fritz JM. Responsiveness of the numeric pain rating scale in patients with low back pain. Spine (Phila Pa 1976). 2005 Jun 1;30(11):1331-4. doi: 10.1097/01.brs.0000164099.92112.29.

    PMID: 15928561BACKGROUND
  • Dascal J, Reid M, IsHak WW, Spiegel B, Recacho J, Rosen B, Danovitch I. Virtual Reality and Medical Inpatients: A Systematic Review of Randomized, Controlled Trials. Innov Clin Neurosci. 2017 Feb 1;14(1-2):14-21. eCollection 2017 Jan-Feb.

    PMID: 28386517BACKGROUND
  • Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole MR. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001 Nov;94(2):149-158. doi: 10.1016/S0304-3959(01)00349-9.

    PMID: 11690728BACKGROUND
  • Houtman IL, Bakker FC. The anxiety thermometer: a validation study. J Pers Assess. 1989 Fall;53(3):575-82. doi: 10.1207/s15327752jpa5303_14.

    PMID: 2778618BACKGROUND
  • Indovina P, Barone D, Gallo L, Chirico A, De Pietro G, Giordano A. Virtual Reality as a Distraction Intervention to Relieve Pain and Distress During Medical Procedures: A Comprehensive Literature Review. Clin J Pain. 2018 Sep;34(9):858-877. doi: 10.1097/AJP.0000000000000599.

    PMID: 29485536BACKGROUND
  • Kamper SJ, Apeldoorn AT, Chiarotto A, Smeets RJ, Ostelo RW, Guzman J, van Tulder MW. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ. 2015 Feb 18;350:h444. doi: 10.1136/bmj.h444.

    PMID: 25694111BACKGROUND
  • Westenberg RF, Zale EL, Heinhuis TJ, Ozkan S, Nazzal A, Lee SG, Chen NC, Vranceanu AM. Does a Brief Mindfulness Exercise Improve Outcomes in Upper Extremity Patients? A Randomized Controlled Trial. Clin Orthop Relat Res. 2018 Apr;476(4):790-798. doi: 10.1007/s11999.0000000000000086.

    PMID: 29480886BACKGROUND

Related Links

Study Officials

  • David S Binder, MD

    Spaulding Rehabilitation Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Innovation

Study Record Dates

First Submitted

January 17, 2019

First Posted

January 29, 2019

Study Start

April 8, 2019

Primary Completion

July 9, 2019

Study Completion

September 1, 2019

Last Updated

February 23, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations